A case of an elderly woman with concurrent pancreatic cancer and slowly progressive type 1 diabetes mellitus

Masaki Tanaka, Ansa Kobayashi, Masahiro Asakawa, Momoko Akihisa, Atsuko Miyake, Mitsunobu Kawamura, Yoshihiro Ogawa

Research output: Contribution to journalArticle

Abstract

The patient was a 76-year-old woman who had been diagnosed with diabetes when she was 75 years of age. Her blood glucose was initially well controlled by oral antidiabetic therapy. However, she was admitted to our hospital at approximately 6 months after her diagnosis because her casual blood glucose and HbAlc suddenly increased to 675 mg/dL and 11.9 %, respectively, and she also developed ketosis. An investigation to determine the cause of her blood glucose deterioration revealed pancreatic cancer. However, her anti-GAD antibody titer was also extremely high (124,000 U/mL), and she was diagnosed as simultaneously having slowly progressive insulin-dependent diabetes mellitus (SPIDDM). The development of SPIDDM in elderly patients is rare and there have only been a few reports about SPIDDM being diagnosed concurrently with pancreatic cancer. HLA genes were detected in the present patient. These genes are potentially related to disease resistance. It is possible that disease resistance HLA led to the simultaneous development of SPIDDM and pancreatic cancer in this elderly patient. Although pancreatic cancer and SPIDDM rarely occur simultaneously in elderly patients, the possible combination of a malignant tumor and type 1 diabetes mellitus (such as SPIDDM) should be considered if a patient's blood glucose control suddenly deteriorates during diabetes treatment.

Original languageEnglish
Pages (from-to)806-812
Number of pages7
JournalJournal of the Japan Diabetes Society
Volume60
Issue number12
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Type 1 Diabetes Mellitus
Pancreatic Neoplasms
Blood Glucose
Disease Resistance
Ketosis
Hypoglycemic Agents
Genes
Anti-Idiotypic Antibodies
Therapeutics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

A case of an elderly woman with concurrent pancreatic cancer and slowly progressive type 1 diabetes mellitus. / Tanaka, Masaki; Kobayashi, Ansa; Asakawa, Masahiro; Akihisa, Momoko; Miyake, Atsuko; Kawamura, Mitsunobu; Ogawa, Yoshihiro.

In: Journal of the Japan Diabetes Society, Vol. 60, No. 12, 01.01.2017, p. 806-812.

Research output: Contribution to journalArticle

Tanaka, Masaki ; Kobayashi, Ansa ; Asakawa, Masahiro ; Akihisa, Momoko ; Miyake, Atsuko ; Kawamura, Mitsunobu ; Ogawa, Yoshihiro. / A case of an elderly woman with concurrent pancreatic cancer and slowly progressive type 1 diabetes mellitus. In: Journal of the Japan Diabetes Society. 2017 ; Vol. 60, No. 12. pp. 806-812.
@article{608634558b3b429eb83e771cc861bc4b,
title = "A case of an elderly woman with concurrent pancreatic cancer and slowly progressive type 1 diabetes mellitus",
abstract = "The patient was a 76-year-old woman who had been diagnosed with diabetes when she was 75 years of age. Her blood glucose was initially well controlled by oral antidiabetic therapy. However, she was admitted to our hospital at approximately 6 months after her diagnosis because her casual blood glucose and HbAlc suddenly increased to 675 mg/dL and 11.9 {\%}, respectively, and she also developed ketosis. An investigation to determine the cause of her blood glucose deterioration revealed pancreatic cancer. However, her anti-GAD antibody titer was also extremely high (124,000 U/mL), and she was diagnosed as simultaneously having slowly progressive insulin-dependent diabetes mellitus (SPIDDM). The development of SPIDDM in elderly patients is rare and there have only been a few reports about SPIDDM being diagnosed concurrently with pancreatic cancer. HLA genes were detected in the present patient. These genes are potentially related to disease resistance. It is possible that disease resistance HLA led to the simultaneous development of SPIDDM and pancreatic cancer in this elderly patient. Although pancreatic cancer and SPIDDM rarely occur simultaneously in elderly patients, the possible combination of a malignant tumor and type 1 diabetes mellitus (such as SPIDDM) should be considered if a patient's blood glucose control suddenly deteriorates during diabetes treatment.",
author = "Masaki Tanaka and Ansa Kobayashi and Masahiro Asakawa and Momoko Akihisa and Atsuko Miyake and Mitsunobu Kawamura and Yoshihiro Ogawa",
year = "2017",
month = "1",
day = "1",
doi = "10.11213/tonyobyo.60.806",
language = "English",
volume = "60",
pages = "806--812",
journal = "Journal of the Japan Diabetes Society",
issn = "0021-437X",
publisher = "Japan Diabetes Society",
number = "12",

}

TY - JOUR

T1 - A case of an elderly woman with concurrent pancreatic cancer and slowly progressive type 1 diabetes mellitus

AU - Tanaka, Masaki

AU - Kobayashi, Ansa

AU - Asakawa, Masahiro

AU - Akihisa, Momoko

AU - Miyake, Atsuko

AU - Kawamura, Mitsunobu

AU - Ogawa, Yoshihiro

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The patient was a 76-year-old woman who had been diagnosed with diabetes when she was 75 years of age. Her blood glucose was initially well controlled by oral antidiabetic therapy. However, she was admitted to our hospital at approximately 6 months after her diagnosis because her casual blood glucose and HbAlc suddenly increased to 675 mg/dL and 11.9 %, respectively, and she also developed ketosis. An investigation to determine the cause of her blood glucose deterioration revealed pancreatic cancer. However, her anti-GAD antibody titer was also extremely high (124,000 U/mL), and she was diagnosed as simultaneously having slowly progressive insulin-dependent diabetes mellitus (SPIDDM). The development of SPIDDM in elderly patients is rare and there have only been a few reports about SPIDDM being diagnosed concurrently with pancreatic cancer. HLA genes were detected in the present patient. These genes are potentially related to disease resistance. It is possible that disease resistance HLA led to the simultaneous development of SPIDDM and pancreatic cancer in this elderly patient. Although pancreatic cancer and SPIDDM rarely occur simultaneously in elderly patients, the possible combination of a malignant tumor and type 1 diabetes mellitus (such as SPIDDM) should be considered if a patient's blood glucose control suddenly deteriorates during diabetes treatment.

AB - The patient was a 76-year-old woman who had been diagnosed with diabetes when she was 75 years of age. Her blood glucose was initially well controlled by oral antidiabetic therapy. However, she was admitted to our hospital at approximately 6 months after her diagnosis because her casual blood glucose and HbAlc suddenly increased to 675 mg/dL and 11.9 %, respectively, and she also developed ketosis. An investigation to determine the cause of her blood glucose deterioration revealed pancreatic cancer. However, her anti-GAD antibody titer was also extremely high (124,000 U/mL), and she was diagnosed as simultaneously having slowly progressive insulin-dependent diabetes mellitus (SPIDDM). The development of SPIDDM in elderly patients is rare and there have only been a few reports about SPIDDM being diagnosed concurrently with pancreatic cancer. HLA genes were detected in the present patient. These genes are potentially related to disease resistance. It is possible that disease resistance HLA led to the simultaneous development of SPIDDM and pancreatic cancer in this elderly patient. Although pancreatic cancer and SPIDDM rarely occur simultaneously in elderly patients, the possible combination of a malignant tumor and type 1 diabetes mellitus (such as SPIDDM) should be considered if a patient's blood glucose control suddenly deteriorates during diabetes treatment.

UR - http://www.scopus.com/inward/record.url?scp=85040059669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040059669&partnerID=8YFLogxK

U2 - 10.11213/tonyobyo.60.806

DO - 10.11213/tonyobyo.60.806

M3 - Article

AN - SCOPUS:85040059669

VL - 60

SP - 806

EP - 812

JO - Journal of the Japan Diabetes Society

JF - Journal of the Japan Diabetes Society

SN - 0021-437X

IS - 12

ER -